These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

850 related items for PubMed ID: 10468952

  • 1. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J.
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
    [Abstract] [Full Text] [Related]

  • 2. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ, Fisker S, Gravholt CH, Bennett P, Svenstrup B, Andersen M, Feldt-Rasmussen U, Christiansen JS, Jørgensen JO.
    Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
    [Abstract] [Full Text] [Related]

  • 3. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A, Kaufman JM, Giagulli VA.
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [Abstract] [Full Text] [Related]

  • 4. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
    Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS.
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
    [Abstract] [Full Text] [Related]

  • 5. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
    Stomati M, Hartmann B, Spinetti A, Mailand D, Rubino S, Albrecht A, Huber J, Petraglia F, Genazzani AR.
    J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
    [Abstract] [Full Text] [Related]

  • 6. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM, Kaltsas GA, Perry L, Burrin JM, Besser GM, Monson JP.
    Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
    [Abstract] [Full Text] [Related]

  • 7. Women With Turner Syndrome Are Both Estrogen and Androgen Deficient: The Impact of Hormone Replacement Therapy.
    Viuff MH, Just J, Brun S, Dam TV, Hansen M, Melgaard L, Hougaard DM, Lappe M, Gravholt CH.
    J Clin Endocrinol Metab; 2022 Jun 16; 107(7):1983-1993. PubMed ID: 35302622
    [Abstract] [Full Text] [Related]

  • 8. Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids.
    Gravholt CH, Frystyk J, Flyvbjerg A, Orskov H, Christiansen JS.
    Am J Physiol Endocrinol Metab; 2001 Feb 16; 280(2):E308-14. PubMed ID: 11158935
    [Abstract] [Full Text] [Related]

  • 9. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH, Naeraa RW, Fisker S, Christiansen JS.
    J Clin Endocrinol Metab; 1997 Aug 16; 82(8):2570-7. PubMed ID: 9253336
    [Abstract] [Full Text] [Related]

  • 10. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
    Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P, Kaaks R.
    Eur J Endocrinol; 2004 Feb 16; 150(2):161-71. PubMed ID: 14763914
    [Abstract] [Full Text] [Related]

  • 11. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids].
    Vondra K, Hampl R, Nĕmcová D, Hill M, Hoza J, Kot'átková A, Stárka L, Vrbíková J, Zamrazil V.
    Cas Lek Cesk; 2002 Feb 15; 141(3):89-95. PubMed ID: 11925670
    [Abstract] [Full Text] [Related]

  • 12. Increased disorderliness and decreased mass and daily rate of endogenous growth hormone secretion in adult Turner syndrome: the impact of body composition, maximal oxygen uptake and treatment with sex hormones.
    Gravholt CH, Veldhuis JD, Christiansen JS.
    Growth Horm IGF Res; 1998 Aug 15; 8(4):289-98. PubMed ID: 10984320
    [Abstract] [Full Text] [Related]

  • 13. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 14. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort.
    Leifke E, Gorenoi V, Wichers C, Von Zur Mühlen A, Von Büren E, Brabant G.
    Clin Endocrinol (Oxf); 2000 Dec 11; 53(6):689-95. PubMed ID: 11155090
    [Abstract] [Full Text] [Related]

  • 15. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
    Milewicz T, Krzysiek J, Janczak-Saif A, Sztefko K, Krzyczkowska-Sendrakowska M.
    Endokrynol Pol; 2005 Dec 11; 56(6):883-90. PubMed ID: 16821206
    [Abstract] [Full Text] [Related]

  • 16. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Fertil Steril; 2001 Mar 11; 75(3):554-9. PubMed ID: 11239541
    [Abstract] [Full Text] [Related]

  • 17. Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients.
    Lønning PE, Helle SI, Johannessen DC, Adlercreutz H, Lien EA, Tally M, Ekse D, Fotsis T, Anker GB, Hall K.
    Clin Endocrinol (Oxf); 1995 Jan 11; 42(1):23-30. PubMed ID: 7534218
    [Abstract] [Full Text] [Related]

  • 18. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone.
    Haeusler G, Schmitt K, Blümel P, Plöchl E, Waldhör T, Frisch H.
    J Clin Endocrinol Metab; 1996 Feb 11; 81(2):536-41. PubMed ID: 8636264
    [Abstract] [Full Text] [Related]

  • 19. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.
    Bannink EM, van Sassen C, van Buuren S, de Jong FH, Lequin M, Mulder PG, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2009 Feb 11; 70(2):265-73. PubMed ID: 19200215
    [Abstract] [Full Text] [Related]

  • 20. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH, Chen JW, Oxvig C, Overgaard MT, Christiansen JS, Frystyk J, Flyvbjerg A.
    Growth Horm IGF Res; 2006 Feb 11; 16(5-6):332-9. PubMed ID: 17067837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.